Clinical Trial Update: Evaluation of the Efficacy of Combination Treatment With Anakinra and Pegsunercept in Improving Rheumatoid Arthritis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the combination of anakinra and pegsunercept for rheumatoid arthritis has completed, assessing efficacy outcomes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• KINERET (ANAKINRA)
• Pegsunercept (pegylated soluble TNF receptor I)

Snippet

Sponsor: Amgen | Conditions: Rheumatoid Arthritis | Phase 2 | Status: COMPLETED